In ER-/PR-/HER2- breast cancer, ADR could activate CHK1 to regulate cell cycle arrest mediated by MCC-APC/C-cyclinB1 axis and apoptosis induced by MSX2 and BIM. Here, MSX2 is linked to breast carcinoma.